Telmisartan (40mg) + Chlorthalidone (12.5mg) + Cilnidipine (10mg)
Vintel-CtC Tablet is used in the treatment of high blood pressure.
1 Strip of 10 Tablet
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Vintel-CtC Tablet is to be taken with food.
Vintel-CtC Tablet is a combination of three medicines: Telmisartan, Cilnidipine and Chlorthalidone. Telmisartan is an angiotensin receptor blocker (ARB) and Cilnidipine is a calcium channel blocker (CCB). They work by widening and relaxing the blood vessels, thereby lowering blood pressure. Chlorthalidone is a diuretic which removes extra water and certain electrolytes from the body through urine. Over time it also works by relaxing blood vessels and improving blood flow.
Related Warnings
Taking Chlorthalidone with alcohol may have additive effects in lowering your blood pressure. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate.
Vintel-CtC Tablet is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
No information is available on the use of Vintel-CtC Tablet during lactation. Please consult your doctor.
Vintel-CtC Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Vintel-CtC Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Vintel-CtC Tablet may be needed. Please consult your doctor.
Use of Vintel-CtC Tablet is not recommended in these patients.
Vintel-CtC Tablet should be used with caution in patients with liver disease. Dose adjustment of Vintel-CtC Tablet may be needed. Please consult your doctor.
Use of Vintel-CtC Tablet is not recommended in patients with severe liver disease.
